Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.
about
How to select the best available related or unrelated donor of hematopoietic stem cells?Haploidentical Stem Cell Transplantation in Adult Haematological MalignanciesNonmyeloablative allogeneic hematopoietic cell transplantationThe Gut Microbiota and Immune System Relationship in Human Graft-versus-Host DiseaseHLA Haplotype Mismatch Transplants and Posttransplant CyclophosphamideRisk factors for relapse after allogeneic transplantation in acute myeloid leukemiaAdoptive T-cell therapy for cancer: The era of engineered T cells[Authorization of tissue and blood stem cell preparations for hematopoietic reconstitution: Documentation of clinical and nonclinical data in a central expert report].Quality control and assurance in hematopoietic stem cell transplantation data registries in Japan and other countries.The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantation.Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.Haematopoietic stem cell transplantation for autoimmune diseases.Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the AHigh-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting.A review of hematopoietic cell transplantation in China: data and trends during 2008-2016.Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment.Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey.Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working party.Sexual health in hematopoietic stem cell transplant recipients.High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unImpact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia WAnti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplantDiagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.Methods of ex vivo expansion of human cord blood cells: challenges, successes and clinical implications.Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agents.The role of tandem stem cell transplantation for multiple myeloma patients.Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report.Cord blood transplant for acute myeloid leukaemia.Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma.The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy.The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis.Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.What do we need to know about allogeneic hematopoietic stem cell transplant survivors?Alloreactivity: the Janus-face of hematopoietic stem cell transplantation.Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review.Stem cell transplantation during cancer.Current practices for screening, consent and care of related donors in France: Haematopoietic stem cell transplantation coordinator nurses' perceptions.
P2860
Q26744109-25D85449-9284-4312-A214-982582C70639Q26745527-F51C5A2D-A41D-42E9-8377-F2602B0FE874Q26748780-9656E893-636A-4BAB-86C0-098040B32A3AQ26751265-3F7F090B-4ADD-458D-83EB-3785C7371C75Q26752908-646BB1E0-D99A-4338-AB46-9613925B7139Q26771438-10257C76-BEB9-4684-8A27-24160640253BQ26800611-513E0F9D-FB25-438F-9DC1-B0A2F8D84F06Q31004560-950E16A4-046B-489A-AA00-0D5D54C7AE92Q31022472-ADDDEDB2-D201-43F4-848D-C05FE6F5B0DCQ33424223-DA5F40ED-7C47-4143-956E-EA53C14DD041Q33742940-415F016D-99C2-4C7F-BCE3-5E99EF4BE5D8Q34551863-7BA88B3A-22DF-4093-9550-54657B105003Q36125603-F1769EB5-69E2-4E7C-A376-6B28DA5292F5Q36287792-D48420E2-62EA-4FD7-9E3B-5FA56AAD50F9Q36354948-7E0E382C-FF0A-4E2D-B858-64C360BA56E2Q36650103-B534BCA8-AF75-42EF-9D87-C2D2E52AA856Q36957809-CE78DD99-73DE-42A1-8670-A83CEC1ED092Q36974379-09CD9AFD-F0FD-4C6D-A85E-A1185C926CE8Q37079011-ABE6E990-1BBA-4519-A31F-FF00A65AD46AQ37148409-45F56DD5-434B-4761-82F6-90CD472DCD39Q37239517-E357B35A-9C3D-46F3-AEAF-17BB49C1F6A0Q37317226-372986D5-7279-4903-85AE-8FEB64033DB7Q37602434-A7D97154-F4DD-43A6-8FD0-F66FCFB74832Q37618811-EB13EA51-DB41-483F-AE8A-EE838A963D6DQ37618840-993AA061-0A4F-470D-BEE8-D745D8B7597CQ37624593-3775592A-8842-4D18-9AC6-AE3E4C37263CQ38658670-61F9BBFE-E95A-401A-8DD7-076C11CD77CEQ38664909-983C38A1-9E98-4079-9D2A-3B1AFCECCC6FQ38677358-9E62FD1E-9940-4EBF-B5FC-35074555B7BDQ38690071-8E60D173-8FDD-45CA-B671-FB9DEE1D0B61Q38696346-56409F68-F448-49CB-BB90-8AC6340FDB1FQ38707629-F7F598A8-A178-43FE-A3EF-62A7955B0614Q38728327-72C344E6-3A36-48D5-9112-03C98AB7F63CQ38790014-A8897F65-2CDC-46E4-8488-09A2484A5303Q38797546-523BEB3D-1815-42C3-BF59-53ED642D6A2FQ38804386-993907F4-27DA-4F02-8EA4-7C7F8F2F902FQ38922235-21503972-79AC-4501-883F-D03D00CB4526Q39005626-11225005-307F-41CC-9406-F23065A81791Q39095853-C061EB7C-C1B0-4B95-9E6F-826ABE982C5AQ39127376-AF69668B-7F72-49EA-B9D2-1E3CBEFA628C
P2860
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Hematopoietic SCT in Europe 20 ...... fewer cord blood transplants.
@ast
Hematopoietic SCT in Europe 20 ...... fewer cord blood transplants.
@en
type
label
Hematopoietic SCT in Europe 20 ...... fewer cord blood transplants.
@ast
Hematopoietic SCT in Europe 20 ...... fewer cord blood transplants.
@en
prefLabel
Hematopoietic SCT in Europe 20 ...... fewer cord blood transplants.
@ast
Hematopoietic SCT in Europe 20 ...... fewer cord blood transplants.
@en
P2093
P2860
P50
P356
P1476
Hematopoietic SCT in Europe 20 ...... t fewer cord blood transplants
@en
P2093
D Farge-Bancel
European Society for Blood and Marrow Transplantation (EBMT)
H Baldomero
J H F Falkenburg
P2860
P2888
P304
P356
10.1038/BMT.2014.312
P407
P577
2015-02-02T00:00:00Z